Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension.
Saved in:
| Title: | Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension. |
|---|---|
| Authors: | Augustin M; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Feldman SR; Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Salford, Greater Manchester, United Kingdom.; Division of Musculoskeletal and Dermatological Sciences, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom., Armstrong A; Division of Dermatology, University of California, Los Angeles., Vender R; Dermatrials Research Inc., Hamilton, Ontario, Canada., López-Ferrer A; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Dawe WH; National Psoriasis Foundation, Portland, Oregon., Lambert J; UCB, Colombes, France., Szilagyi B; UCB, Monheim am Rhein, Germany., Hoepken B; UCB, Monheim am Rhein, Germany., Warham R; Veramed, London, United Kingdom.; UCB, Slough, United Kingdom., Gottlieb AB; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas. |
| Source: | JAMA dermatology [JAMA Dermatol] 2026 Apr 01; Vol. 162 (4), pp. 359-367. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6084 |
|---|---|
| DOI: | 10.1001/jamadermatol.2025.6055 |